Nathalie Dubois-Stringfellow, SVP-chief Development Officer: Sangamo Therapeutics SGMOQ Planned sale · Filed 04/06

Trade details

Type: Planned sale notice
Stock: Sangamo Therapeutics SGMOQ
Person: Nathalie Dubois-StringfellowSVP-chief Development Officer
Planned sale date: 26/04/06
Filed: 26/04/06

0.1% of shares outstanding to be sold

Sangamo Therapeutics trades, last 26 weeks

What else happened in Sangamo Therapeutics around then

Filed or reported within 30 days of the trade day · 03/07~05/06

Nathalie Dubois-Stringfellow's recent trades

Nathalie Dubois-StringfellowSVP-chief Development Officer
SellSangamo Therapeutics
Sell
Sangamo Therapeutics
SGMOQ
$89.9K
345,942 sh
$89.9K
Filed 04/23
Traded 04/21